Tag: pharmaceuticals
-
FDA Updating Expanded Access to Investigational Drugs, Devices
The Food and Drug Administration says it’s streamlining policies for making drugs and medical devices in clinical trials or under review available for people in the U.S. with life-threatening conditions.
-
Trial Underway for Inhaled Heart Rhythm Drug, Developer Raises $42M
A clinical trial is underway testing an inhaled therapy to quickly treat irregular heart rhythms, in cases where the problems occur occasionally and often resolve on their own.
-
Modified Cancer Drug Hastens Bone Fracture Healing
A current drug for leukemia, with a simple protein chemically added, is shown in tests with lab mice to accelerate the healing of broken bones.
-
Nanotech Immunotherapy Reduces Heart Transplant Rejection
Proteins known to regulate immune cells, given as nanoscale particles, are shown in lab mice to encourage long-term acceptance of a transplanted heart.
-
NIH Award Supports Esophagus Tissue Implants from Stem Cells
A company developing engineered tissue implants from stem cells received a grant from National Institutes of Health to develop an implant to correct a congenital defect in a newborn infant’s esophagus.
-
New Processes Devised to Boost Antibiotics
Researchers in chemistry at two institutions report new techniques that lab tests show modify current antibiotics to make them more effective against infections that resist today’s antibiotics.
-
Infographic – Growing Interest in Longevity Research
A chart showing a growing journalistic interest in topics related to human longevity, this weekend’s infographic.
-
Rapid Antimicrobial Resistance Diagnostics System Advances
Developers of a system that uses high-speed genomic analysis with standard semiconductor chips say they demonstrated an ability to sequence bacterial DNA directly from raw blood samples.
-
FDA Clears Some Drug Reaction Genetic Tests, Warns About Others
The Food and Drug Administration cleared a consumer genetics company’s tests for gene variations associated with effective or adverse drug reactions, but warned about similar tests from non-authorized providers.
-
FDA Preparing Animal, Plant Biotech Regulatory Guidance
The Food and Drug Administration intends to issue new regulatory guidance to cover advances in biotechnology, including genome editing, in animals and plants.